| Authors: |
Bianchi G; Amyloidosis Program, Dana Farber Cancer Institute/Brigham and Women's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. Electronic address: giada_bianchi@dfci.harvard.edu., Sanchorawala V; Amyloidosis Center, Boston University Chobanian and Avedisian School of Medicine and Boston Medical Center, Boston, MA, USA., Wechalekar A; National Amyloidosis Centre, University College London and University College London Hospitals, London, UK., Grogan M; Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA., Cuddy SAM; Amyloidosis Program, Dana Farber Cancer Institute/Brigham and Women's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA, USA., Merlini G; Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy; Department of Molecular Medicine, University of Pavia, Pavia, Italy. |
